Advanced Cell Technology Inc (OTCQB:ACTC)

Data as of Oct 21
 -0.03 / -0.42%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Advanced Cell Technology, Inc. is a biotechnology company, engaged in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. It is actively conducting clinical trials for treating dry age-related macular degeneration and Stargardt's macular degeneration, in addition to several clinical and preclinical programs for other ocular therapies. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company's intellectual property portfolio includes pluripotent human embryonic stem cell, or hESC; induced pluripotent stem cell, or iPSC, platforms; and other cell therapy research programs. Advanced Cell Technology was founded on May 18, 2000 and is headquartered in Marlborough, MA.

Contact Information

Advanced Cell Technology, Inc.
33 Locke Drive
Marlborough Massachusetts 01752
P:(508) 756-1212
Investor Relations:



Individual stakeholders2.11%
Mutual fund holders--
Other institutional--

Top Executives

Paul K. WottonPresident, Chief Executive Officer & Director
Edward H. MylesChief Operating & Financial Officer
Robert P. LanzaChief Scientific Officer
Eddy AngladeExecutive Vice President-Clinical Development
Shi-Jiang LuSenior Director-Research

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.